News and Trends 29 Sep 2022
NeuShen Therapeutics closes $20M pre-A financing
Chinese biotech company NeuShen Therapeutics, Inc. has closed an approximately $20 million series pre-A financing led by LAPAM, a China based venture capital. The new capital will be used to…